Works matching IS 22351795 AND DT 2022 AND VI 11 AND IP 1

Results: 9

Front & Back Matter.
Published in:
Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 1, doi. 10.1159/000522097
Publication type:
Article
Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma.
Published in:
2022
By:
- Kudo, Masatoshi
Publication type:
Editorial
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials.
Published in:
Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 75, doi. 10.1159/000520278
By:
- Cabibbo, Giuseppe;
- Reig, Maria;
- Celsa, Ciro;
- Torres, Ferran;
- Battaglia, Salvatore;
- Enea, Marco;
- Rizzo, Giacomo Emanuele Maria;
- Petta, Salvatore;
- Calvaruso, Vincenza;
- Di Marco, Vito;
- Craxì, Antonio;
- Singal, Amit G.;
- Bruix, Jordi;
- Cammà, Calogero
Publication type:
Article
Efficacy and Safety of 4 Fractions of Carbon-Ion Radiation Therapy for Hepatocellular Carcinoma: A Prospective Study.
Published in:
Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 61, doi. 10.1159/000520277
By:
- Shibuya, Kei;
- Katoh, Hiroyuki;
- Koyama, Yoshinori;
- Shiba, Shintaro;
- Okamoto, Masahiko;
- Okazaki, Shohei;
- Araki, Kenichiro;
- Kakizaki, Satoru;
- Shirabe, Ken;
- Ohno, Tatsuya
Publication type:
Article
Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma.
Published in:
Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 48, doi. 10.1159/000519868
By:
- Kobayashi, Kazufumi;
- Ogasawara, Sadahisa;
- Takahashi, Aya;
- Seko, Yuya;
- Unozawa, Hidemi;
- Sato, Rui;
- Watanabe, Shunji;
- Moriguchi, Michihisa;
- Morimoto, Naoki;
- Tsuchiya, Satoshi;
- Iwai, Kenji;
- Inoue, Masanori;
- Ogawa, Keita;
- Ishino, Takamasa;
- Iwanaga, Terunao;
- Sakuma, Takafumi;
- Fujita, Naoto;
- Kanzaki, Hiroaki;
- Koroki, Keisuke;
- Nakamura, Masato
Publication type:
Article
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.
Published in:
Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 38, doi. 10.1159/000519867
By:
- Rimassa, Lorenza;
- Kelley, Robin Kate;
- Meyer, Tim;
- Ryoo, Baek-Yeol;
- Merle, Philippe;
- Park, Joong-Won;
- Blanc, Jean-Frederic;
- Lim, Ho Yeong;
- Tran, Albert;
- Chan, Yi-Wah;
- McAdam, Paul;
- Wang, Evelyn;
- Cheng, Ann-Lii;
- El-Khoueiry, Anthony B.;
- Abou-Alfa, Ghassan K.
Publication type:
Article
APPLE News.
Published in:
2022
Publication type:
Proceeding
Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection.
Published in:
Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 22, doi. 10.1159/000518940
By:
- Tsai, Ming-Chao;
- Wang, Chih-Chi;
- Lee, Wei-Chen;
- Lin, Chih-Che;
- Chang, Kuo-Chin;
- Chen, Chien-Hung;
- Hung, Chao-Hung;
- Lin, Ming-Tsung;
- Hsiao, Chang-Chun;
- Chen, Chao-Long;
- Chien, Rong-Nan;
- Hu, Tsung-Hui
Publication type:
Article
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.
Published in:
Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 9, doi. 10.1159/000518619
By:
- Ng, Kennedy Yao Yi;
- Tan, Sze Huey;
- Tan, Jack Jie En;
- Tay, Desiree Shu Hui;
- Lee, Ailica Wan Xin;
- Ang, Andrea Jing Shi;
- Wong, Lawrence Wen Jun;
- Choo, Su Pin;
- Tai, David Wai-Meng;
- Lee, Joycelyn Jie Xin
Publication type:
Article